Medications and Their Toxicity

[1]  U. Ernström,et al.  Export and import of lymphocytes in the thymus during steroid-induced involution and regeneration. , 2009, Acta pathologica et microbiologica Scandinavica.

[2]  R. Aur,et al.  Acute lymphocytic leukemia in children , 1975, Cancer.

[3]  R Storb,et al.  Bone-marrow transplantation (second of two parts). , 1975, The New England journal of medicine.

[4]  E. Henderson,et al.  Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. , 1975, The New England journal of medicine.

[5]  F. Oski,et al.  Syndrome of recurrent increased secretion of antidiuretic hormone following multiple doses of vincristine. , 1975, Blood.

[6]  A. Einstein,et al.  Suppression of secondary cellular immunity to a tumor allograft by cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea. , 1975, Cancer research.

[7]  Y. Hirshaut,et al.  In vitro combination chemotherapy demonstrating potentiation of vincristine cytotoxicity by prednisolone. , 1975, Cancer research.

[8]  P. Wiernik,et al.  Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. , 1975, Annals of internal medicine.

[9]  J. Pinkhas,et al.  Endocardial fibrosis following busulfan treatment. , 1975, JAMA.

[10]  Y. Ahn,et al.  Vincristine therapy of idiopathic and secondary thrombocytopenias. , 1974, The New England journal of medicine.

[11]  H. Weiss,et al.  Neurotoxicity of commonly used antineoplastic agents (first of two parts). , 1974, The New England journal of medicine.

[12]  Santos Gw.  Immunosuppression for clinical marrow transplantation. , 1974 .

[13]  Young Rc,et al.  Hematologic malignancies and other marrow failure states: progress in the management of complicating infections. , 1974 .

[14]  P. Clements,et al.  Human lymphocyte subpopulations. Effect of corticosteroids. , 1974, The Journal of clinical investigation.

[15]  J. Yates,et al.  A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients , 1973, Cancer.

[16]  W. Roberts,et al.  Cardiac ultrastructural changes induced by daunorubicin therapy , 1973, Cancer.

[17]  T. Fliedner,et al.  Gnotobiotic care of patients with immunologic deficiency diseases. , 1973, Transplantation proceedings.

[18]  V. Oliverio,et al.  The effects of antibiotics and cancer chemotherapeutic agents on the cellular transport and antitumor activity of methotrexate in L1210 murine leukemia. , 1973, Cancer research.

[19]  R. Benjamin,et al.  Pharmacokinetics and metabolism of adriamycin in man , 1973, Clinical pharmacology and therapeutics.

[20]  R. DeFronzo,et al.  Water intoxication in man after cyclophosphamide therapy. Time course and relation to drug activation. , 1973, Annals of internal medicine.

[21]  S. Perry,et al.  Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia. , 1973, The New England journal of medicine.

[22]  A. W. Harris,et al.  Differentiated functions expressed by cultured mouse lymphoma cells. II. Theta antigen, surface immunoglobulin and a receptor for antibody on cells of a thymoma cell line. , 1973, Journal of immunology.

[23]  Krueger Gr.  Chronic immunosuppression and lymphomagenesis in man and mice. , 1972 .

[24]  G. Elfenbein,et al.  THE COMPARATIVE EFFECTS OF SELECTED CYTOTOXIC AGENTS ON TRANSPLANTED HEMATOPOIETIC CELLS , 1972, Transplantation.

[25]  S. Perry,et al.  Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria. , 1972, The New England journal of medicine.

[26]  E. Henderson,et al.  Hematuria and crystalluria after high-dose 6-mercaptopurine administration. , 1972, The New England journal of medicine.

[27]  J. Holland,et al.  Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli , 1972, Cancer.

[28]  Young Rc,et al.  Management of infections in patients with leukemia and lymphoma: current concepts and experimental approaches. , 1972, Seminars in hematology (Print).

[29]  I. Djerassi,et al.  Continuous Flow Filtration—Leukopheresis , 1972, Transfusion.

[30]  H. Maibach,et al.  Use of methotrexate in psoriasis. , 1972, Archives of dermatology.

[31]  P. Klener,et al.  [Immunosuppressive therapy of idiopathic thrombocytopenia]. , 1972, Vnitrni lekarstvi.

[32]  J. Holland,et al.  Corticosteroid administration and localized leukocyte mobilization in man. , 1972, The New England journal of medicine.

[33]  J. Turk,et al.  Selective depletion of lymphoid tissue by cyclophosphamide. , 1972, Clinical and experimental immunology.

[34]  Ruth R. Atkinson,et al.  Paraplegia following intrathecal chemotherapy , 1972, Cancer.

[35]  N. Bethlenfalvay,et al.  Severe cerebral toxicity after intravenous nitrogen mustard therapy , 1972, Cancer.

[36]  P. Neiman,et al.  High‐dose cyclophosphamide therapy for malignant disease. Toxicity, tumor response, and the effects of stored autologous marrow , 1972 .

[37]  K. Bagshawe,et al.  Complication of methotrexate-maintained remission in lymphoblastic leukemia. , 1971, British medical journal.

[38]  J. Whitecar,et al.  Pharmacology of 6-thioguanine in man. , 1971, Cancer research.

[39]  E. Henderson,et al.  Reduced production of spleen colonies and granulocytes in antibiotic-treated irradiated mice transplanted with syngeneic bone marrow. , 1971, Radiation research.

[40]  K. Bischoff,et al.  Methotrexate pharmacokinetics. , 1971, Journal of pharmaceutical sciences.

[41]  B. Leventhal,et al.  Cytosine arabinoside in acute granulocytic leukemia , 1971, Clinical pharmacology and therapeutics.

[42]  R. Adamson,et al.  Neoplasms of the hematopoietic system in nonhuman primates: report of one spontaneous tumor and two leukemias induced by procarbazine. , 1971, Journal of the National Cancer Institute.

[43]  C. Craddock,et al.  Cell replication in the primary hemolysin response: the effect of six mercaptopurine. , 1971, Journal of the Reticuloendothelial Society.

[44]  P. Scheuer,et al.  Liver Damage due to Methotrexate in Patients with Psoriasis , 1971, British medical journal.

[45]  C. Berard,et al.  MALIGNANT LYMPHOMAS AND PLASMACYTOSIS IN MICE UNDER PROLONGED IMMUNOSUPPRESSION AND PERSISTENT ANTIGENIC STIMULATION , 1971, Transplantation.

[46]  W. Zschiesche,et al.  Alkylating anticancer agents and phagocytosis. I. Effects of a homologous series of 1,2-substituted 5-bis(beta-chloroethyl)-amino-benzimidazole derivatives on carbon clearance. , 1970, Journal of the Reticuloendothelial Society.

[47]  P. B. Stewart,et al.  Procarbazine as an immunosuppressant in animals. , 1970, Journal of immunology.

[48]  L. Elveback,et al.  THE IMMUNOSUPPRESSIVE EFFECT OF ANTILYMPHOCYTE SERA PRODUCED BY SENSITIZATION WITH DIFFERENT LYMPHOID TISSUES , 1970, Transplantation.

[49]  A. Hirano,et al.  Some effects of vinblastine implantation in the cerebral white matter. , 1970, Laboratory investigation; a journal of technical methods and pathology.

[50]  R. Guttmann,et al.  RENAL TRANSPLANTATION IN THE INBRED RAT: XV. An Assay Study of Three Immunosuppressive Drugs , 1970, Transplantation.

[51]  E. Lance.  The selective action of antilymphocyte serum on recirculating lymphocytes: a review of the evidence and alternatives. , 1970, Clinical and experimental immunology.

[52]  V. Devita,et al.  The effect of chemotherapy on the growth characteristics and cellular kinetics of leukemia L1210. , 1970, Cancer research.

[53]  A. W. Harris.  Differentiated functions expressed by cultured mouse lymphoma cells. I. Specificity and kinetics of cell responses to corticosteroids. , 1970, Experimental cell research.

[54]  J. Bach,et al.  [Analytic study of 69 anti-mouse lymphocyte rabbit serums. II. "In vitro" activity]. , 1970, Pathologie-biologie.

[55]  C. Jasmin,et al.  Bone Marrow Graft in Man after Conditioning by Antilymphocytic Serum* , 1970, British medical journal.

[56]  W. Doleschel,et al.  Autosomal deletion syndrome 46,XX,18p-: a new case report with absence of IgA in serum. , 1970, Journal of medical genetics.

[57]  P. Nettesheim,et al.  Effect of Immunosuppressive Agents on Retention of Antigen in the Mouse Spleen 1 , 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[58]  H. Oettgen,et al.  L‐asparaginase activity in plasma and other biological fluids , 1970, Cancer.

[59]  V. Devita,et al.  Plasma Pyridoxal Phosphate Depletion by the Carcinostatic Procarbazine , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[60]  G. Cartwright,et al.  Pulmonary disease complicating intermittent therapy with methotrexate. , 1969, JAMA.

[61]  D. Vredevoe,et al.  Effect of antilymphocytic and antithymocytic sera on the development of mouse lymphoma. , 1969, Cancer research.

[62]  E. Lance.  THE MECHANISM OF ACTION OF ANTI-LYMPHOCYTE SERUM , 1969, The Journal of experimental medicine.

[63]  H. O'kane,et al.  The Distribution of Rabbit Anti-Mouse Thymus Globulin After Injection into Mice∗ , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[64]  J. Sheagren,et al.  Alternate-day prednisone therapy. Evaluation of delayed hypersensitivity responses, control of disease and steroid side effects. , 1969, The New England journal of medicine.

[65]  P. B. Stewart,et al.  Antiserum to Lymphocytes and Procarbazine Compared as Immunosuppressants in Mice , 1969, Science.

[66]  P. Gill.  Cytophilic antibody in heterologous antilymphocytic serum: its presence, absorption and possible biologic significance. , 1969, Journal of immunology.

[67]  J. White,et al.  Methotrexate liver toxicity. , 1969, The Journal of pediatrics.

[68]  E. Henderson,et al.  Vincristine‐induced neuropathy , 1969, Neurology.

[69]  T. Starzl,et al.  Malignant lymphomas in transplantation patients. , 1969, Transplantation proceedings.

[70]  R. Genova,et al.  L-asparaginase and blastogenesis. , 1969, Lancet.

[71]  R. E. Chanes,et al.  Renal toxicity of methotrexate , 1969, Cancer.

[72]  P. Lampert,et al.  NEURONAL CHANGES INDUCED BY INTRATHECAL VINCRISTINE SULFATE , 1968, Journal of neuropathology and experimental neurology.

[73]  J. A. Crim,et al.  THE IMMUNOSUPPRESSIVE ACTIVITY OF ARA-CYTIDINE: I. Effects on Antobody-Forming Cells and Humoral Antibody , 1968, Transplantation.

[74]  H. M. Liu,et al.  ULTRASTURCTURE OF CENTERAL NERVOUS SYSTEM LESIONS IN METACHROMATIC LEUKKODYSTROPHY WITH SPECIAL REFERENCE TO MORPHOGENESIS , 1968 .

[75]  J. Furth,et al.  Inhibition of Mammalian DNA Polymerase by the 5′-Triphosphate of 1-β-d-Arabinofuranosylcytosine and the 5′-Triphosphate of 9-β-d-Arabinofuranosyladenine , 1968 .

[76]  Creasey Wa.  Modifications in biochemical pathways produced by the Vinca alkaloids. , 1968 .

[77]  M. Hirsch,et al.  Effects of Anti-thymocyte Serum on Rauscher Virus Infection of Mice , 1968, Nature.

[78]  A. Allison,et al.  Effects of Antilymphocyte Serum on Virus Oncogenesis , 1968, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[79]  E. Henderson,et al.  Ocular complications of vincristine therapy. , 1967, Archives of ophthalmology.

[80]  S. Perry,et al.  The effect of etiocholanolone on granulocyte kinetics. , 1967, Blood.

[81]  A. Erslev,et al.  "Selective" pituitary insufficiency secondary to busulfan. , 1967, Annals of internal medicine.

[82]  C. Carpenter,et al.  RENAL TRANSPLANTATION IN THE INBRED RAT , 1967, The Journal of experimental medicine.

[83]  L. J. Cole,et al.  RESISTANCE OF LONG-LIVED LYMPHOCYTES AND PLASMA CELLS IN RAT LYMPH NODES TO TREATMENT WITH PREDNISONE, CYCLOPHOSPHAMIDE, 6-MERCAPTOPURINE, AND ACTINOMYCIN D , 1967, The Journal of experimental medicine.

[84]  A. Rivarola,et al.  Methotrexate and the immune response. , 1967, Transplantation.

[85]  A. D'Agostino,et al.  Neuropathy in lymphoblastic leukemia treated with vincristine. , 1967, Archives of neurology.

[86]  R. Levey,et al.  SOME EXPERIMENTS ON THE ACTION OF ANTILYMPHOID ANTISERA , 1966 .

[87]  E. Hersh,et al.  Hepatotoxic effects of methotrexate , 1966, Cancer.

[88]  A. Owens,et al.  19S and 7S Antibody Production in the Cyclophosphamide- or Methotrexate-treated Rat , 1966, Nature.

[89]  A. Monaco,et al.  Studies on heterologous anti-lymphocyte serum in mice. II. Effect on the immune response. , 1966, Journal of immunology.

[90]  Y. S. Sathe,et al.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. , 1966, Annals of internal medicine.

[91]  V. Oliverio,et al.  Monoamine Oxidase Inhibition by a New Carcinostatic Agent, N-Isopropyl-α-(2-Methylhydrazino)-p-Toluamide (MIH) , 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[92]  M. Webber,et al.  Antithymic Antibody Localization in the Mouse , 1965, Nature.

[93]  R. Schwartz,et al.  Malignant Lymphomas Following Allogenic Disease: Transition from an Immunological to a Neoplastic Disorder , 1965, Science.

[94]  E. Henderson,et al.  The metabolic fate of tritiated methotrexate. I. Absorption, excretion, and distribution in mice, rats, dogs and monkeys. , 1965, Cancer research.

[95]  E. Henderson,et al.  The metabolic fate of tritiated methotrexate. II. Absorption and excretion in man. , 1965, Cancer research.

[96]  H. Maibach,et al.  IMMUNOLOGIC COMPETENCE OF PATIENTS WITH PSORIASIS RECEIVING CYTOTOXIC DRUG THERAPY. , 1965, Archives of dermatology.

[97]  A. Beckett,et al.  SIDE-EFFECTS OF DRUGS. , 1965, Lancet.

[98]  G. Astaldi,et al.  [THE EFFECT OF DAUNOMYCIN ON THE PROLIFERATIVE ACTIVITY OF STEM-CELLS OBTAINED IN CULTURE OF NORMAL HUMAN BLOOD]. , 1964, Tumori.

[99]  V. Oliverio,et al.  CARCINOGENIC ACTIVITY OF A NEW ANTITUMOR AGENT, N-ISOPROPYL-ALPHA-(2-METHYLHYDRAZINO)-P-TOLUAMIDE, HYDROCHLORIDE (NSC-77213). , 1964, Cancer chemotherapy reports.

[100]  G. Cartwright,et al.  THE EFFECT OF ADRENAL GLUCOCORTICOSTEROIDS UPON THE CELLULAR COMPOSITION OF INFLAMMATORY EXUDATES. , 1964, The American journal of pathology.

[101]  R. Auerbach,et al.  PARENTERAL METHOTREXATE IN PSORIASIS. , 1964, Archives of dermatology.

[102]  A. Burger.  Entstehung, Wachstum und Chemotherapie maligner Tumoren. , 1963 .

[103]  A. White.  HORMONAL INFLUENCES ON IMMUNE MECHANISMS. , 1963, Annals of allergy.

[104]  P. Carbone,et al.  Clinical studies with vincristine. , 1963, Blood.

[105]  R. Schwartz,et al.  A syndrome resembling adrenal cortical insufficiency associated with long term busulfan (myleran) therapy. , 1961, Blood.

[106]  D. Berliner,et al.  HORMONAL INFLUENCE ON LYMPHOCYTE DIFFERENTIATION FROM RES CELLS * , 1960, Annals of the New York Academy of Sciences.

[107]  D. Boggs.  The cellular composition of inflammatory exudates in human leukemias. , 1960, Blood.

[108]  R. Schwartz,et al.  Effect of 6-Mercaptopurine on Antibody Production.∗ , 1958, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[109]  E. Dubois.  Nitrogen mustard in treatment of systemic lupus erythematosus. , 1954, A.M.A. archives of internal medicine.

[110]  J. Robson,et al.  Intracorneal murine leprosy and its response to isoniazid. , 1953, Lancet.

[111]  J. Oyama,et al.  Influence of Cortisone on Experimental Hypersensitivity and Circulating Antibody in the Guinea Pig , 1952, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[112]  J. Perianes,et al.  Treatment of rheumatoid arthritis with nitrogen mustard; preliminary report. , 1951, Journal of the American Medical Association.

[113]  P. Hench,et al.  The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. , 1949, Proceedings of the staff meetings. Mayo Clinic.

[114]  L. Hektoen,et al.  The effect of mustard gas (dichlorethyl-sulphid) on antibody formation , 1921 .

[115]  A. Fauci,et al.  Alternate-day prednisone therapy and human lymphocyte subpopulations. , 1975, The Journal of clinical investigation.

[116]  R. Adamson,et al.  Toxicity of antineoplastic agents in man, chromosomal aberrations antifertility effects, congenital malformations, and carcinogenic potential. , 1975, Advances in cancer research.

[117]  A. Sartorelli,et al.  Antineoplastic and Immunosuppressive Agents , 1975, Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology.

[118]  H. Madoc‐Jones,et al.  Site of Action of Cytotoxic Agents in the Cell Life Cycle , 1974 .

[119]  J. E. Harris,et al.  Clinical Utility of Immunosuppressive Agents , 1974 .

[120]  B. Kim,et al.  Favorable remission induction rate with twice weekly doses of L-asparaginase. , 1973, Cancer research.

[121]  H. Friedman,et al.  Virus tumorigenesis and immunogenesis , 1973 .

[122]  G. Krueger,et al.  Morphology of chemical immunosuppression. , 1972, Advances in pharmacology and chemotherapy.

[123]  W. Wechter,et al.  Immunosuppression--agents, procedures, speculations and prognosis. , 1972, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[124]  A. Macdonald,et al.  Use of procarbazine hydrochloride (natulan) and procarbazine hydrochloride and azathioprine in canine renal allografts. , 1971, Transplantation.

[125]  E. Henderson,et al.  Therapy of acute leukemia with drug combinations which include asparaginase , 1971, Cancer.

[126]  A. Kolin,et al.  Effect of actinomycin D on the tuberculin skin reaction in guinea pigs. , 1970, International archives of allergy and applied immunology.

[127]  B. P. Maclaurin,et al.  Macrophage specificity of antiserum against thymus lymphocytes. , 1970, Clinical and experimental immunology.

[128]  Taub Tn.  Biological effects of heterologous antilymphocyte serum. , 1970 .

[129]  J. Revillard,et al.  Production of human antilymphocytic serum in horse with thoracic duct lymphocytes and peripheral blood lymphocytes. , 1970, Federation proceedings.

[130]  E. Hersh,et al.  Leukocytic mechanisms in inflammation. , 1970, Annual review of medicine.

[131]  M. Dardenne,et al.  Etude analytique de 69 serums de lapin anti-lymphocytes de souris. I. - Activites 'in vivo'. , 1970 .

[132]  B. Jennings.  The immunosuppressive effects of actinomycin D and radiation. , 1969, Journal of the Reticuloendothelial Society.

[133]  S. Farber,et al.  Continuous infusion of methotrexate in children with acute leukemia , 1967, Cancer.

[134]  R. Good,et al.  Chemical suppression of adaptive immunity. , 1967, Advances in immunology.

[135]  R. Smalley,et al.  Two cases of busulfan toxicity. , 1966, Annals of internal medicine.

[136]  J. Turk.  STUDIES ON THE MECHANISM OF ACTION OF METHOTREXATE AND CYCLOPHOSPHAMIDE ON CONTACT SENSITIVITY IN THE GUINEA PIG. , 1964, International archives of allergy and applied immunology.